The Effects of Transversus Abdominis Plane Block in Patients Undergoing Total Abdominal Hysterectomy (TAP)

February 25, 2016 updated by: Tuğba Karaman, Tokat Gaziosmanpasa University

The Effects of TAP Block on Hemodynamic Variables, Anaesthetic and Analgesic Requirement and Quality of Recovery in Patients Undergoing Total Abdominal Hysterectomy

The purpose of this study is to determine the effects of Transversus Abdominis Plane Block on hemodynamic variables, anaesthetic and analgesic requirement, and quality of recovery in patients undergoing total abdominal hysterectomy

Study Overview

Detailed Description

Pain is one of the main causes of the poor perioperative outcomes and pain management is the important part of perioperative period. Neuraxial blocks could provide adequate analgesia during and after abdominal surgery. However,neuraxial blocks have a lot of contraindicated situations and neuraxial anesthesia can easily induce hemodynamic abnormalities. Therefore, in most cases, the choice of anaesthetic management may be the general anesthesia. In addition to reduce the blood pressure and heart rate changes due to surgical stimulations, the large amount of opioids and anaesthetics may be required. Opioid related side effects can affect perioperative complications and postoperative quality of recovery. Transversus abdominis plane block is a new choice to reduce postoperative pain in abdominal surgery. Although its postoperative analgesic efficacy is well known, its effects on hemodynamic variables, anaesthetic and analgesic requirement is not clear. The main objective of this study is to estimate the effect of Transversus abdominis plane block on hemodynamic variables, anaesthetic and analgesic requirement and quality of recovery in patients undergoing total abdominal hysterectomy.

Study Type

Interventional

Enrollment (Actual)

66

Phase

  • Phase 4

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Merkez
      • Tokat, Merkez, Turkey, 60100
        • Gaziosmanpasa University Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 65 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

Female

Description

Inclusion Criteria:

  • Adult (18-65years old)
  • American Society of Anesthesiologists (ASA) physical status I-II
  • Patients scheduled for elective total abdominal hysterectomy under general anesthesia

Exclusion Criteria:

  • ASA physical status ≥ 3
  • Allergy to local anesthetics
  • Drug abuse or addiction
  • Bleeding tendency

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Supportive Care
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: TAP Block
Using real time ultrasound imaging, bilateral, 20 ml 0,25% bupivacaine inject into the area between the internal oblique and transverse abdominis muscle
Using real time ultrasound imaging, bilateral, 20 ml 0,25% bupivacaine inject into the area between the internal oblique and transverse abdominis muscle
Other Names:
  • Transversus abdominis plane block
Sham Comparator: Control
A sham band-aid will be applied to the abdomen of subjects who are randomized to the no intervention group.
A sham band-aid will be applied to the abdomen of subjects
Other Names:
  • sham group

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
intraoperative opioid consumption
Time Frame: during anaesthesia
The overall intravenous remifentanyl consumption (microgram/ kilogram) during the surgery. The decision to administer remifentanyl is guided by the changes of blood pressure and/ or heart rate greater than 20% from baseline level.
during anaesthesia

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Quality of recovery
Time Frame: postoperative 24 hours
quality of recovery 40 form will use to assessment the recovery
postoperative 24 hours
Postoperative nausea and vomiting
Time Frame: postoperative 0.,2.,12.,24 hours
nausea score(0-3) and number of vomiting will be recorded
postoperative 0.,2.,12.,24 hours
postoperative pain
Time Frame: postoperative 0,2,12,24 hours
visual analog scale will be used
postoperative 0,2,12,24 hours
intraoperative hemodynamic variables
Time Frame: during anaesthesia
arterial blood pressure, heart rate changes will be recorded
during anaesthesia
intraoperative anaesthetic consumption
Time Frame: during anaesthesia
anaesthetic consumption will be calculated
during anaesthesia

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Tuğba Karaman, MD, GOU

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

September 1, 2014

Primary Completion (Actual)

February 1, 2016

Study Completion (Actual)

February 1, 2016

Study Registration Dates

First Submitted

November 13, 2014

First Submitted That Met QC Criteria

November 18, 2014

First Posted (Estimate)

November 20, 2014

Study Record Updates

Last Update Posted (Estimate)

February 26, 2016

Last Update Submitted That Met QC Criteria

February 25, 2016

Last Verified

February 1, 2016

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • GaziosmanpashaU

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Intraoperative Complications

Clinical Trials on TAP block

3
Subscribe